Artillegence Bio-Innovations Profile
Key Indicators
- Authorised Capital ₹ 7.40 Cr
as on 22-12-2024
- Paid Up Capital ₹ 7.32 Cr
as on 22-12-2024
- Company Age 41 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 23.34%
(FY 2022)
- Profit -61.68%
(FY 2022)
- Ebitda -61.63%
(FY 2022)
- Net Worth
- Total Assets
About Artillegence Bio-Innovations
The Company is engaged in the Business Outsourcing Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 7.40 Cr and a paid-up capital of Rs 7.32 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Artillegence Bio-Innovations Limited India are Vivek Dadriwal as Company Secretary, Pragati Bajaj as Company Secretary, and Sony Singh as Cfo. Sony Singh, Jay Singh, and Anil Das serve as directors at the Company.
- CIN/LLPIN
L51219WB1983PLC036190
- Company No.
036190
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
16 Apr 1983
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Listed
- ROC Code
Roc Kolkata
Industry
Company Details
- Location
Howrah, West Bengal, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Artillegence Bio-Innovations?
Executive Team (4)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Jay Singh | Managing Director | 01-Apr-2023 | Current |
Vivek Dadriwal | Company Secretary | 04-Apr-2023 | Current |
Pragati Bajaj | Company Secretary | 04-Apr-2023 | Current |
Sony Singh | CFO | 17-Apr-2023 | Current |
Board Members(2)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Sony Singh | Director | 01-Apr-2023 | Current |
Anil Das | Director | 01-Feb-2024 | Current |
Financial Performance of Artillegence Bio-Innovations.
Artillegence Bio-Innovations Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 23.34% increase. The company also saw a substantial fall in profitability, with a 61.68% decrease in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets | |||||||
Profit or Loss |
| ||||||
Net Worth | |||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Artillegence Bio-Innovations?
In 2022, Artillegence Bio-Innovations had a promoter holding of 0.03% and a public holding of 99.97%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Stocknet International LtdActive 41 years 9 months
Sony Singh, Jay Singh and 2 more are mutual person
- New Outlook Securities LtdActive 42 years 3 months
Sony Singh, Jay Singh and 1 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Artillegence Bio-Innovations?
Unlock and access historical data on people associated with Artillegence Bio-Innovations, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Artillegence Bio-Innovations, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Artillegence Bio-Innovations's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.